Arbor Life Labs has technology that regulates the Wnt/beta-Catenin pathway complemented by modulating disease and tissue specific molecular targets. We develop tissue regenerative therapeutics to address dermatology conditions, degenerative disease and immune regulation. Arbor's lead dermatology platform ALRV5XR, sets a new standard of care for androgenic alopecia, telogen effluvium and senescent alopecia in women and men. Our addressable market exceeds $50 billion with rapid time to commercialization by following a non-drug regulatory pathway.

Arbor Life Labs Logo



Event details

Date: June 10 - 17, 2021

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences


30 in total